The team at Atomo Diagnostics is delighted to announce that it has been selected as the winner of the Johnson & Johnson Innovation Industry Excellence, Emerging Company of the Year Award for 2014. The award was announced as part of the AusBiotech opening address, held at The Gold Coast Convention Centre, on Wednesday October 29th 2014.
The Emerging Company of the Year award recognizes companies that have demonstrated significant achievements during the year. Johnson & Johnson Innovation’s selected Atomo Diagnostics based on its extensive commercialisation efforts with the innovative AtomoRapid™ test.
Atomo Diagnostics Founder & CEO John Kelly said: “We are delighted to be recognised for the work we are doing in providing convenient, accurate and user friendly products to the market for important infectious and chronic diseases. Receiving this prestigious award sponsored by Johnson & Johnson Innovation is very encouraging”.